Molecular Partners AG MOLN
2.49 USD -0.17 (-6.57%)
Regular-session close
2.56 +0.07 +2.81%
After hours · Nov 19, 4:10 PM ET
2.67 Day range 2.77
2.63 52-week range 5.36
- YTD
- -42.89%
- 1 year
- -40.57%
Analyst view
Price target (mean) 10.37 +316.6% upside
Now 2.49
- Target (low)
- 5.03
- Target (mean)
- 10.37
- Target (high)
- 16.46
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Included in Essentials and up
Sign in to see Revenue and earnings forecast
Reported revenue and earnings per share by year, then what analysts expect next.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.39 | -0.39 – -0.39 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Current year | -1.61 | -1.68 – -1.53 | -1.89 | +15.1% | 5.00M | -28.6% | 2 |
| Next year | -1.64 | -1.79 – -1.49 | -1.61 | -2.2% | 5.00M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2023 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 29, 2022 | SVB Leerink | Downgrade | Outperform | Market Perform |
| May 25, 2022 | Credit Suisse | Upgrade | Underperform | Neutral |
| Apr 27, 2022 | SVB Leerink | Maintained | — | Outperform |
| Jan 14, 2022 | SVB Leerink | Maintained | — | Outperform |
| Aug 27, 2021 | SVB Leerink | Maintained | — | Outperform |
| Jul 13, 2021 | Cowen & Co. | Initiated | — | Outperform |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
